Dr. Ingrid Scheffer
Claim this profileAustin Hospital
Studies Syndrome
Studies Lennox Gastaut Syndrome
6 reported clinical trials
6 drugs studied
Clinical Trials Ingrid Scheffer is currently running
Carisbamate
for Lennox-Gastaut Syndrome
The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic) compared with placebo in pediatric and adult subjects (age 4-55 years) diagnosed with Lennox Gastaut Syndrome (LGS).
Recruiting1 award Phase 315 criteria
Cenobamate
for Epilepsy
Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures
Recruiting2 awards Phase 312 criteria
More about Ingrid Scheffer
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ingrid Scheffer has experience with
- Soticlestat
- Placebo
- Placebo Oral Liquid
- ANAVEX2-73 Oral Liquid
- Cenobamate
- Carisbamate
Breakdown of trials Ingrid Scheffer has run
Syndrome
Lennox Gastaut Syndrome
Myoclonic Epilepsy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ingrid Scheffer specialize in?
Ingrid Scheffer focuses on Syndrome and Lennox Gastaut Syndrome. In particular, much of their work with Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Ingrid Scheffer currently recruiting for clinical trials?
Yes, Ingrid Scheffer is currently recruiting for 3 clinical trials in Heidelberg West Victoria. If you're interested in participating, you should apply.
Are there any treatments that Ingrid Scheffer has studied deeply?
Yes, Ingrid Scheffer has studied treatments such as Soticlestat, Placebo, Placebo oral liquid.
What is the best way to schedule an appointment with Ingrid Scheffer?
Apply for one of the trials that Ingrid Scheffer is conducting.
What is the office address of Ingrid Scheffer?
The office of Ingrid Scheffer is located at: Austin Hospital, Heidelberg West, Victoria 3081 Australia. This is the address for their practice at the Austin Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.